Method of treating cancer in a patient by administering an antibody which binds colony stimulating factor-1 receptor (CSF-1R)

US11542335B2 · kind B2 · utility

Assignee

• Hoffmann-La Roche Inc. · US

Inventors

• Sabine Hoves · Penzberg, DE
• Chia-Huey Ooi · Wyhlen, DE
• Carola Ries · Penzberg, DE
• Solange Romagnoli · Basel, CH
• Dominik RUETTINGER · Seehausen, DE
• Hadassah Sumum Sade · Penzberg, DE

Key dates

• Filing date: Feb 25, 2019
• Grant date: Jan 3, 2023
• Expiry date: Feb 25, 2039

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07K2317/76
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The current invention relates to the intermittent dosing of an anti-CSF-1R antibody in combination with macrophage activating agent, corresponding pharmaceutical compositions or medicaments using such combination therapy.